1. HBsAg loss is enough to discontinue long-term nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B patients in real practice?. (15th February 2015) Authors: Fasano, M.; Ciarallo, M.; Niro, G.; Fontana, R.; Cozzolongo, R.; Maci, A.; Carraturo, I.; Miglietta, A.; Angarano, G.; Santantonio, T. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗